The global dermal filler market was valued at $5.18 billion in 2021, and is projected to reach $14.41 billion by 2031, registering a CAGR of 10.8% from 2022 to 2031. Dermal filler is defined as an aesthetic procedure, which is injected beneath the surface of the skin to add fullness & volume, smooth lines & soften creases, and increase the facial contours. It is widely used for facial aesthetic treatment. The different types of dermal filler are hyaluronic acid, calcium hydroxylapatite, polylactic acid, and polymethyl-methacrylate microspheres. It is used to enhance or fill the shallow areas on the face. In addition, this procedure is mostly used among population to reduce wrinkle under eyes.
The growth of the global dermal filler market is majorly driven by an alarming increase in demand for minimally invasive procedure; rise in government initiative for the advancement of dermal filler procedure; surge in the number of approvals for dermal filler' products; and a rise in adoption of hyaluronic acid. According to the journal of Dermatology & Mohs Surgery Institute, it was analyzed that dermal filler is one of the leading minimally invasive skin procedure, globally. For instance, in 2021, Deloitte, one of the leading professional services companies, reported that around 9.53% of hyaluronic acid is consumed in China. Thus, the increase in prevalence of hyaluronic acid boosts the demand for dermal filler procedure.
Moreover, in 2021, the U.S. Food and drug Administration (FDA) announced the approval of RHA Redensity Dermal Filler, which is used for the treatment of moderate to severe dynamic perioral rhytids (lip lines) in the adults above the age of 22. Furthermore, in 2021, Revance Therapeutics, Inc., a biotechnology company, presented data on the effectiveness and safety of the RHA collection of dermal filler. It is one of the latest advances in hyaluronic acid filler technology, which is used for the treatment of moderate-to-severe nasolabial folds in darker skin color. The increase in advancements in dermal filler technology aims to obtain long-lasting, and effective results. Thus, advancements in technology for advanced dermal filler products in emerging nations are expected to propel the growth of the market.
The increase in government support for aesthetic procedure and surge in demand for aesthetic procedure are the major factors that drive the global dermal filler market. For instance, in February 2022, the GOV.UK announced to introduce a licensing regime for non-surgical cosmetic procedures such as dermal filler and Botox. This step aims to protect the public against botch fillers and botox. In addition, increase in the number of anti-aging treatment significantly contributes toward the market growth. Rise in demand for aesthetic looks among young population acts a key driving force for the expansion of the global market.
However, the high cost associated with dermal filler procedure is anticipated to hinder the market growth. Increase in prevalence of early skin aging, surge the need for hyaluronic acid and drive the growth of the market. This has further encouraged many key players to enter emerging markets, thus offering a lucrative growth opportunity in the dermal filler market.
The dermal filler market is segmented into type, gender, service provider, and region. By type, the market is categorized into hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly-L-lactic acid, and others. The others segment is further divided into polymethyl-methacrylate microspheres (PMMA) and fat face. By gender, it is bifurcated into male and female. By service provider, the market is classified into specialty & dermatology clinics, hospitals, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global dermal filler market are include AbbVie Laboratories, Bioxis pharmaceutical, Cutera Inc., Elan aesthetics Inc., Galderma SA, Merz Pharma GmbH & Co. KGaA, Revance Therapeutics, Sinclair Pharma, Teoxane Laboratories, and Vital Esthetique Laboratories.
The growth of the global dermal filler market is majorly driven by an alarming increase in demand for minimally invasive procedure; rise in government initiative for the advancement of dermal filler procedure; surge in the number of approvals for dermal filler' products; and a rise in adoption of hyaluronic acid. According to the journal of Dermatology & Mohs Surgery Institute, it was analyzed that dermal filler is one of the leading minimally invasive skin procedure, globally. For instance, in 2021, Deloitte, one of the leading professional services companies, reported that around 9.53% of hyaluronic acid is consumed in China. Thus, the increase in prevalence of hyaluronic acid boosts the demand for dermal filler procedure.
Moreover, in 2021, the U.S. Food and drug Administration (FDA) announced the approval of RHA Redensity Dermal Filler, which is used for the treatment of moderate to severe dynamic perioral rhytids (lip lines) in the adults above the age of 22. Furthermore, in 2021, Revance Therapeutics, Inc., a biotechnology company, presented data on the effectiveness and safety of the RHA collection of dermal filler. It is one of the latest advances in hyaluronic acid filler technology, which is used for the treatment of moderate-to-severe nasolabial folds in darker skin color. The increase in advancements in dermal filler technology aims to obtain long-lasting, and effective results. Thus, advancements in technology for advanced dermal filler products in emerging nations are expected to propel the growth of the market.
The increase in government support for aesthetic procedure and surge in demand for aesthetic procedure are the major factors that drive the global dermal filler market. For instance, in February 2022, the GOV.UK announced to introduce a licensing regime for non-surgical cosmetic procedures such as dermal filler and Botox. This step aims to protect the public against botch fillers and botox. In addition, increase in the number of anti-aging treatment significantly contributes toward the market growth. Rise in demand for aesthetic looks among young population acts a key driving force for the expansion of the global market.
However, the high cost associated with dermal filler procedure is anticipated to hinder the market growth. Increase in prevalence of early skin aging, surge the need for hyaluronic acid and drive the growth of the market. This has further encouraged many key players to enter emerging markets, thus offering a lucrative growth opportunity in the dermal filler market.
The dermal filler market is segmented into type, gender, service provider, and region. By type, the market is categorized into hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly-L-lactic acid, and others. The others segment is further divided into polymethyl-methacrylate microspheres (PMMA) and fat face. By gender, it is bifurcated into male and female. By service provider, the market is classified into specialty & dermatology clinics, hospitals, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global dermal filler market are include AbbVie Laboratories, Bioxis pharmaceutical, Cutera Inc., Elan aesthetics Inc., Galderma SA, Merz Pharma GmbH & Co. KGaA, Revance Therapeutics, Sinclair Pharma, Teoxane Laboratories, and Vital Esthetique Laboratories.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the dermal filler market analysis from 2021 to 2031 to identify the prevailing dermal filler market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the dermal filler market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global dermal filler market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Key Market Segments
By Type
- Hyaluronic acid (HA)
- Age group
- 13 to 39
- 40 to 54
- 55 to 69
- Calcium Hydroxylapatite (CaHA)
- Poly L lactic Acid
- Others
By Gender
- Male
- Female
By Service Provider
- Specialty and Dermatology Clinics
- Hospitals
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Teoxane Laboratories
- Cutera Inc
- Elan aesthetics Inc
- Bioxis pharmaceutical
- AbbVie Laboratories
- Sinclair Pharma
- Sosum Global
- Revance Therapeutics
- Galderma SA
- Merz Pharma
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: DERMAL FILLER MARKET, BY TYPE
CHAPTER 5: DERMAL FILLER MARKET, BY GENDER
CHAPTER 6: DERMAL FILLER MARKET, BY SERVICE PROVIDER
CHAPTER 7: DERMAL FILLER MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
According to this report, titled, 'Dermal Filler Market,'The global dermal filler market size was valued at $5,184.8 million in 2021, and is projected to reach $14,418.4 million by 2031, registering a CAGR of 10.8% from 2022 to 2031. Dermal filler is defined as a gel like substance, which is injected into the face to enhance shallow contours, plump thin lips, remove wrinkles, soften facial creases, and diminish the appearance of the scars. Hyaluronic acid is one of the most common types of dermal filler used among the population. Dermal filler is injected by the healthcare providers around the eyes, mouth, and nose. Dermal filler procedures aim to gain youthful appearance and enhance the facial features.The factors that drive the growth of the global dermal filler market size include an increase in the prevalence of the geriatric population, technological advancements in dermal filler product, and surge in demand for anti-aging treatment. In addition, the rise in number of injectable fillers procedure in the female population, notably contributes toward the growth of the global market. According to the International Society of Aesthetic Plastic Surgery, in 2020, approximately 2.5 million hyaluronic acid procedure is conducted in the female population across the world. As per the same source, in 2020, approximately 1.3 million hyaluronic acid procedure is conducted in population of the age group between 40 to 54 years. This augments the need for dermal filler products among the geriatric population. Furthermore, market players focus on the manufacturing of advanced dermal filler for aesthetic solution. For instance, in February 2022, Merz Aesthetics, a medical aesthetics company announced the launch of Radiesse (+) Lidocaine injectable implant for deep injection to improve moderate to severe loss of jawline contour in adults over the age of 21 years. Moreover, Galderma is a dermatologist and pharmaceutical company, received approval for two aesthetic products. Thus, increase in number of dermal filler industry to manufacture dermal filler products propels the growth of the market.
In addition, in May 2020, the Food & Drug Administration (FDA) announced the approval for Restylane kysse, a new hyaluronic acid (HA) filler specifically designed and indicated to add fullness to lips and help smoothen wrinkles above the mouth. The FDA aims to enhance the availability of dermal filler product and increase the access to a wide range of dermal filler for consumers.
Moreover, rise in development of medical aesthetic industry and improvement in healthcare spending are anticipated to drive the growth of the dermal filler market. For instance, in 2021, McKinsey & Company, conducted a survey to analyze the use of dermal filler among different age group and income population. It was reported that, the population with annual income of more than $100,000 are the active users of dermal filler. In addition, the increase in the number of female population and rise in self-awareness among young population regarding the physical appearance led to the development of innovative technologies in the aesthetic sector, thereby propelling the growth of the market.
Moreover, the increase in the number of licensed medical centers is the key factor that boosts the growth of the dermal filler market analysis. The reason behind the increasing number of medical centers is attributed to surge in number of non-invasive aesthetic procedures such as dermal filler and botox. Furthermore, the rise in prevalence of skin damage and increase in geriatric female population, who are more vulnerable to wrinkle and facial line, propel the growth of the market. In addition, the rise in disposable income and increase in awareness regarding different facial aesthetic treatments among the female population fuel the dermal filler market trends.
The dermal filler market share is segmented on the basis of type, gender, service provider, and region. On the basis of type, the market is divided into hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly-L-lactic acid, and others. The others segment is further divided into polymethyl-methacrylate microspheres (PMMA) and fat face. The hyaluronic acid segment dominated the market in 2021, and this trend is expected to continue during the dermal filler market forecast period, owing to increase in number of hyaluronic acids-based dermal filler products, advancement in R&D activities in medical aesthetic industry, and rise in prevalence of early aging of the skin.
By gender, it is bifurcated into male and female. The female segment acquired the top position in the market in 2021, and this trend is expected to continue during the forecast period, owing to increase in demand for dermal filler procedures, rapidly growing emphasis on personal aesthetics among females, and rise in number of female populations conducting minimal invasive aesthetic procedure.
As per service provider, the market is classified into specialty & dermatology clinics, hospitals, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The hospitals segment led the market in 2021, and this trend is expected to continue during the forecast period, owing to increase in number of hospitals to conduct dermal filler procedures and rise in expenditure by governments to improve the healthcare industry.
North America accounted for a majority of the global dermal filler market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to a rise in prevalence of early aging of the skin due to external environmental factors, increase in the number of approvals for dermal filler product, the presence of dermal filler industry, and development in technology for dermal filler in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to increase in number of approvals for aesthetic products, the rise in geriatric populations, growth in health care expenditures, and a rise in adoption of dermal filler product.
The COVID-19 outbreak is anticipated to have a negative impact on the growth of the global dermal filler market. A number of clinics and hospitals were restructured to increase hospital capacities for patients diagnosed with COVID-19. Non-essential surgical procedures were cancelled due to the pandemic. Dermal filler procedures are non-emergency procedures that significantly hampered revenue of aesthetic companies. In addition, sudden, sharp cut in a monthly income of the population is anticipated to have a negative impact on the dermal filler market.
Key Findings of The Study
By type, the hyaluronic acid segment was the highest contributor to the market in 2021.By gender, the male segment was the highest contributor to the market in 2021.
By service provider, the hospitals segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
By region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period
Companies Mentioned
- Teoxane Laboratories
- Cutera Inc
- Elan aesthetics Inc
- Bioxis pharmaceutical
- AbbVie Laboratories
- Sinclair Pharma
- Sosum Global
- Revance Therapeutics
- Galderma SA
- Merz Pharma
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 280 |
| Published | July 2024 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 5.18 billion |
| Forecasted Market Value ( USD | $ 14.41 billion |
| Compound Annual Growth Rate | 10.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
